Cardiac tamponade mimicking ventricular rupture after thrombolysis for acute myocardial infarction.
Imperadore
F
F
Spagnolli
W
W
Martinelli
L
L
Musuraca
G
G
De Girolamo
P
P
Maines
M
M
Vergara
G
G
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002305:Cardiac Tamponade / Q000139:chemically induced / Q000175:diagnosis* / Q000601:surgery; D003937:Diagnosis, Differential; D005260:Female; D006341:Heart Rupture / Q000175:diagnosis*; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D005996:Nitroglycerin / Q000627:therapeutic use; D010490:Pericardial Effusion / Q000139:chemically induced* / Q000150:complications; D020519:Pericardiocentesis; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use
D000925:Anticoagulants; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator; D005996:Nitroglycerin; D001241:Aspirin